We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$408M
AUM Growth
+$8.37M
Cap. Flow
-$28.1M
Cap. Flow %
-6.88%
Top 10 Hldgs %
46.4%
Holding
651
New
16
Increased
86
Reduced
178
Closed
103

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$4.6M
2
ANET icon
Arista Networks
ANET
+$1.07M
3
CACI icon
CACI
CACI
+$1.02M
4
PSX icon
Phillips 66
PSX
+$504K
5
EWBC icon
East-West Bancorp
EWBC
+$341K

Sector Composition

Rank Sector Weight
1 Technology 23.33%
2 Financials 20.75%
3 Healthcare 12.08%
4 Consumer Discretionary 9.63%
5 Communication Services 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSXMA
26
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$3.78M 0.93%
127,210
-65
-0.1% -$1.95K
JNJ icon
27
Johnson & Johnson
JNJ
$646B
$3.7M 0.91%
23,395
-997
-4% -$159K
UNP icon
28
Union Pacific
UNP
$183B
$3.31M 0.81%
13,479
-684
-5% -$168K
KO icon
29
Coca-Cola
KO
$386B
$3.23M 0.79%
52,775
-1,150
-2% -$69.1K
HD icon
30
Home Depot
HD
$329B
$3.2M 0.79%
8,354
+16
+0.2% +$5.84K
XOM icon
31
ExxonMobil
XOM
$644B
$3.16M 0.77%
27,202
+285
+1% +$29.8K
EWBC icon
32
East-West Bancorp
EWBC
$17.7B
$3.04M 0.75%
38,472
+4,654
+14% +$341K
UNH icon
33
UnitedHealth
UNH
$353B
$3.04M 0.74%
6,140
-312
-5% -$159K
LW icon
34
Lamb Weston
LW
$7.56B
$2.91M 0.71%
27,358
+172
+0.6% +$17.9K
CSX icon
35
CSX Corp
CSX
$95B
$2.9M 0.71%
78,145
-389
-0.5% -$14.2K
ABBV icon
36
AbbVie
ABBV
$451B
$2.84M 0.7%
15,625
-94
-0.6% -$16.2K
KR icon
37
Kroger
KR
$35.4B
$2.78M 0.68%
48,775
-170
-0.3% -$8.37K
BRK.A icon
38
Berkshire Hathaway Class A
BRK.A
$1.08T
$2.54M 0.62%
4
ABT icon
39
Abbott
ABT
$195B
$2.38M 0.58%
20,969
-207
-1% -$23.7K
PG icon
40
Procter & Gamble
PG
$334B
$2.31M 0.57%
14,250
-146
-1% -$22.9K
ACGL icon
41
Arch Capital
ACGL
$33.7B
$2.14M 0.53%
23,202
+3,051
+15% +$258K
IBB icon
42
iShares Biotechnology ETF
IBB
$10.5B
$2.14M 0.52%
15,571
+1
+0% +$137
ETN icon
43
Eaton
ETN
$156B
$2.13M 0.52%
6,800
-1,223
-15% -$334K
CL icon
44
Colgate-Palmolive
CL
$72.3B
$2.11M 0.52%
23,388
-757
-3% -$64.1K
CP icon
45
Canadian Pacific Kansas City
CP
$82.7B
$1.87M 0.46%
21,209
-75
-0.4% -$6.29K
CRWD icon
46
CrowdStrike
CRWD
$224B
$1.76M 0.43%
22,016
-2,252
-9% -$172K
CRM icon
47
Salesforce
CRM
$211B
$1.62M 0.4%
5,392
-1,061
-16% -$306K
MA icon
48
Mastercard
MA
$521B
$1.54M 0.38%
3,199
-627
-16% -$287K
LLY icon
49
Eli Lilly
LLY
$1.05T
$1.38M 0.34%
1,772
-605
-25% -$431K
PSX icon
50
Phillips 66
PSX
$97.4B
$1.37M 0.34%
8,413
+3,500
+71% +$504K

Similar funds

M&R Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, M&R Capital Management held 651 positions worth $408M, up 2.1% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

M&R Capital Management withdrew a net $28.1M in Q1 2024, closing 103 positions and reducing 178 holdings. Its most notable exit was Martin Marietta Materials, an estimated $244K position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, M&R Capital Management opened a new position in Arista Networks worth $1.15M.

  • M&R Capital Management's largest Q1 2024 buy was Arista Networks: 15,800 shares worth $1.15M.
  • M&R Capital Management added most to 3M in Q1 2024, an estimated $4.6M increase.
  • M&R Capital Management's biggest Q1 2024 reduction was Broadcom, cutting an estimated $13M.
  • M&R Capital Management fully exited Martin Marietta Materials in Q1 2024, selling an estimated $244K.
  • M&R Capital Management's ten largest holdings make up 46% of its $408M portfolio in Q1 2024.
  • M&R Capital Management opened 16 new positions and closed 103 in Q1 2024.
  • M&R Capital Management's portfolio value rose 2.1% quarter-over-quarter to $408M.

Based on M&R Capital Management's 13F filing for Q1 2024, filed 2 Apr 2024.